Long COVID — metabolic risk factors and novel therapeutic management

Cardiometabolic conditions, including type 1 and type 2 diabetes mellitus, are associated with severe COVID-19 and long COVID. Interventions to target multiple risk factors, combined with use of novel glucose-lowering agents that improve metabolic function and the key processes that are impaired in...

Descripción completa

Detalles Bibliográficos
Autores principales: Khunti, Kamlesh, Davies, Melanie J., Kosiborod, Mikhail N., Nauck, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054121/
https://www.ncbi.nlm.nih.gov/pubmed/33875855
http://dx.doi.org/10.1038/s41574-021-00495-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054121/
https://www.ncbi.nlm.nih.gov/pubmed/33875855
http://dx.doi.org/10.1038/s41574-021-00495-0

Ejemplares similares